NEWS & EVENTS
For Immediate Release
December 17, 2008
Contact: Gregg DiPietro
Leerink Swann
(617) 918-4601
Gregg.DiPietro@leerink.com
Contact: Risa Burgess
Schwartz Communications
(781) 684-0770
Leerink@schwartz-pr.com
Leerink Swann Ranks First Place in Institutional Investor’s 2008 All-America Institutional Sales Team, Healthcare Survey
BOSTON, Mass.—December 17, 2008—Leerink Swann, the leading healthcare investment banking firm, today announced that its sales force ranked first in Healthcare institutional sales in Institutional Investor’s 2008 All-America Sales Team survey. This is the second year in a row the firm received the top ranking in this category. Leerink Swann’s sales team also ranked second in the Biotechnology category.
The All-America Sales Team surveys portfolio managers, buy-side analysts, directors of research, chief investment officers and other investment professionals at 506 investment management firms in the United States. Nominations for firms were not pre-listed on the questionnaire forms. Instead, respondents were required to volunteer and write in names in nine industry categories.
“Leerink Swann’s second consecutive first place sales ranking is recognition for our focused healthcare approach and the strength of our dedicated knowledge platform,” said Jeff Leerink, Chairman and CEO, Leerink Swann. “We are particularly appreciative of our clients who were instrumental in honoring us with this recognition. We look forward to continued momentum in the New Year, coupled with our ongoing strong commitment to keeping our clients’ best interests as the driving force in our business.”
Leerink Swann has been selected as “Best of the Boutiques” in multiple healthcare categories for the past seven years by Institutional Investor.
Leerink Swann is a healthcare-focused investment banking firm that provides equity research, corporate finance, strategic advisory, and asset management services for institutional, life sciences, and high-net-worth clients. Every year since 2001, Institutional Investor has named Leerink Swann “Best of the Boutiques” in several healthcare categories. Through its MEDACorp division, Leerink Swann provides biomedical-consulting services to the institutional investment community. With an internal team of experts and a dedicated external network of academic and community healthcare professionals, MEDACorp assesses the viability of cutting-edge medical technologies, thus giving decision makers the information they need to perform. Leerink Swann is a member of FINRA/SIPC. For more information, visit www.leerink.com.
####